Inventor
GIRARD MARIO
US18 patents
⚠️ This page may combine multiple inventors who share the name “GIRARD MARIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK FROSST CANADA INC
8 patentsUS5733909AMar 31, 1998
Diphenyl stilbenes as prodrugs to COX-2 inhibitors
MERCK FROSST CANADA INC110 citations98
US5710170AJan 20, 1998
Tri-aryl ethane derivatives as PDE IV inhibitors
MERCK FROSST CANADA INC108 citations97
US6743802B2Jun 1, 2004
Alkyne-aryl phosphodiesterase-4 inhibitors
MERCK FROSST CANADA INC25 citations92
US6200993B1Mar 13, 2001
Heterosubstituted pyridine derivatives as PDE4 inhibitors
MERCK FROSST CANADA INC30 citations92
US6180650B1Jan 30, 2001
Heterosubstituted pyridine derivatives as PDE 4 inhibitors
MERCK FROSST CANADA INC30 citations90
US6677351B2Jan 13, 2004
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
MERCK FROSST CANADA INC13 citations84
US6399636B2Jun 4, 2002
Tri-aryl-substituted-ethane PDE4 inhibitors
MERCK FROSST CANADA INC9 citations71
US6841564B2Jan 11, 2005
Tri-aryl-substituted-ethane PDE4 inhibitors
MERCK FROSST CANADA INC0 citations50
MILLENNIUM PHARM INC
7 patentsUS9290500B2Mar 22, 2016
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC10 citations82
US10202373B2Feb 12, 2019
Heteroaryls and uses thereof
MILLENNIUM PHARM INC2 citations71
US9802960B2Oct 31, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC4 citations71
US9751854B2Sep 5, 2017
Heteroaryls and uses thereof
MILLENNIUM PHARM INC3 citations71
US10538533B2Jan 21, 2020
Heteroaryls and uses thereof
MILLENNIUM PHARM INC0 citations50
US10202389B2Feb 12, 2019
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50
US9796725B2Oct 24, 2017
Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
MILLENNIUM PHARM INC0 citations50